Allopurinol may cut diabetes patients' risk of cardiac death

09/5/2013 | (U.K.) · Scotsman (Edinburgh), The

Type 2 diabetes patients who received the gout medication allopurinol showed reduced thickness of the heart muscle wall compared with those who took a placebo, according to a small study in the Journal of the American College of Cardiology. The findings suggest that while skin reactions are a common side effect, the drug may help reduce cardiac deaths in diabetes patients.

View Full Article in: (U.K.) · Scotsman (Edinburgh), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX